BiotechTube
Home/Harmony Biosciences/Jeffrey M. Dayno, M.D.
JM

Jeffrey M. Dayno, M.D.

President and Head of Research and Development

Harmony Biosciences

Therapeutic Areas

Sleep/Wake DisordersRare Epilepsies

Harmony Biosciences Pipeline

DrugIndicationPhase
WAKIX (pitolisant)Narcolepsy (Adults)Approved
ZYN002 (transdermal cannabidiol gel)Developmental and Epileptic Encephalopathies (e.g., LGS)Phase 3
EPX-100 (clemizole)Dravet SyndromePhase 1/2
EPX-200Genetic EpilepsiesPreclinical

Leadership Team at Harmony Biosciences

JC
John C. Jacobs
Chairman and Chief Executive Officer
SK
Sandip Kapadia, CPA
Chief Financial Officer
View full Harmony Biosciences profile